COVID-19 is characterized by dysregulated thrombosis and coagulation that can increase
mortality in patients. Platelets are fast responders to pathogen presence, alerting the …

Cardiometabolic disease comprises cardiovascular and metabolic dysfunction and
underlies the leading causes of morbidity and mortality, both within the United States and …

Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Background: The excess risk of cardiovascular disease associated with a wide array of
infectious diseases is unknown. We quantified the short-and long-term risk of major …

Pneumonia is inflammation in the lungs, which is usually caused by an infection. The
symptoms of pneumonia can vary from mild to life-threatening, where severe illness is often …

Although neurological complications of SARS-CoV-2 infection are relatively rare, their
potential long term morbidity and mortality have a significant impact, given the large …

COVID-19 has been associated with an increased risk for thromboembolic events, including
ischemic stroke, venous thromboembolism, and myocardial infarction. Studies have reported …

Soon after the outbreak of coronavirus disease 2019 (COVID-19), unexplained sustained
fatigue, cognitive disturbance, and muscle ache/weakness were reported in patients who …

Atherosclerosis is a chronic inflammatory and degenerative process that mainly occurs in
large-and medium-sized arteries and is morphologically characterized by asymmetric focal …

Coronavirus infectious disease-19 (COVID-19) is a pandemic characterized by serious lung
disease and thrombotic events in the venous and circulation trees, which represent a …